Thalassaemia: open trials in Canada

5 open trials have a site in Canada. Registry data; only the trial team decides who can take part.

NCT06609226
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Trial Treatment · Phase 3 · Novo Nordisk A/S
CHU Ste-Justine, Montreal · University Health Network, Toronto General Hospital, Toronto · The Hospital for Sick Children, Toronto · St Pauls Hospital, Vancouver
Registry updated 2026-09-18
NCT04208529
A Long-term Follow-up Study in Participants Who Received CTX001
Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated
Toronto General Hospital - Hematology, Toronto · Hospital for Sick Children - Hematology, Toronto · St. Paul's Hospital - Hematology, Vancouver
Registry updated 2026-08-11
NCT04064060
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Trial Treatment · Phase 3 · Celgene
Toronto · Toronto · Toronto
Registry updated 2026-07-01
NCT04432623
The BENeFiTS Trial in Beta Thalassemia Intermedia
Trial Treatment · Phase 1/2 · Phoenicia BioScience
University Health Network and Toronto General Hospital, Toronto
Registry updated 2025-08-15
NCT06363760
A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301
Research · Editas Medicine, Inc.
Ottawa Hospital Research Institute, Ottawa · Princess Margaret Cancer Centre - University Health Network, Toronto
Registry updated 2025-04-02

This page is not medical advice. Talk to your doctor before contacting a trial.

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia